Contact Us: 1-800-981-9883
COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. On September 9, 2022, the CDC alerted laboratories that the U.S. Department of Health and Human Services (HHS) has declared that the current circumstances justify the authorization…
COLA Inc., a physician-directed organization whose purpose is to promote health and safety through accreditation and educational programs, is proud to announce that the California Department of Public Health, Laboratory Field Services has recently granted COLA the authority to deem California clinical laboratories to be in compliance with California law for the specialty of Pathology,…
COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. On September 1, 2022, the CDC alerted laboratories about recent variant influenza viral infections. There are five cases of human infection with variant influenza A usually spread…
COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates.
On August 30, 2022, CDC published a best practice for suspected Monkeypox lesion specimen collection.
COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. On August 23, 2022, CDC issued a recommendation to laboratories on how to prevent false positive results for the Monkeypox virus. To prevent false positive test results,…
COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. There are several important announcements for the month of October. You can find more details by clicking on the links below: On August 12, 2022,…
COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. On August 5, 2022, CDC issued a laboratory advisory related to infection prevention and control of Monkeypox in healthcare settings. Also, on August 5th, the Department of…
COLA is honored to participate in celebrating all laboratory heroes during National Medical Laboratory Professionals Week. While the work of laboratorians has been highlighted during the pandemic, these dedicated and sometimes unsung heroes consistently work behind the scenes to provide high quality laboratory testing as a vital part of healthcare. COLA’s Chief Executive Officer, Nancy…
COLA’s CMO, David Chhieng, MD, MBA, MSHI, MSEM, MLS, MDR, was recently listed as one of this year’s Castle Connolly Top Doctors. This list was compiled by Castle Connolly Medical Ltd., which publishes Top Doctors listings to help consumers find the best in healthcare. Castle Connolly’s 2022 Top Doctors represents the top 7 percent of…
